Skip to content

GRAIL, Inc. GRAL Net Change in Cash

Net Change in Cash at other companies

Abbott logo
AbbottABT
-$1.72B-58.6%
Guardant Health logo
Guardant HealthGH
$612.02M+252%
Natera, Inc. logo
Natera, Inc.NTRA
$11.79M-58.2%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-$83.59M+55.7%
Immunome logo
ImmunomeIMNM
-$70.79M-162%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$7.11M+180%

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s net change in cash?
GRAIL, Inc. (GRAL) reported net change in cash of -$180.38M in Q1 2026.
How has GRAIL, Inc.'s net change in cash changed year-over-year?
GRAIL, Inc.'s net change in cash decreased by 124.5% year-over-year, from -$80.34M to -$180.38M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.